Compare Sign (SIGN) vs Venom (VENOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sign vs Venom — how do they compare? Sign trades at Rp113.84 (market cap Rp270,23M, Rp71,45M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Venom is the larger of the two by market cap, and Sign's circulating supply is 2,4B / 10B SIGN (24%) versus 988,9M / 8B VENOM (13%) for Venom. Which is the better fit depends on your goals — on Pluang, investors hold Sign for 21 Days and Venom for 24 Days on average.
| SIGN | VENOM | |
|---|---|---|
Market Cap | Rp270,23M | Rp340,86M |
Volume (24h) | Rp71,45M | Rp2,89M |
Circulating Supply | 2,4B / 10B SIGN (24%) | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 21 Days | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SIGN token currently trades at Rp115.74 with a market cap of Rp275.68M, showing bearish technical signals with 18 sell indicators versus 3 buy signals. The token faces resistance at Rp117-Rp120 while finding support at Rp112-Rp115 levels. With only 24% of the maximum 10M supply in circulation and average hold time of 21 days, the asset shows limited distribution but stable holding patterns among current investors.
Overall outlook remains cautious due to strong bearish technical momentum despite neutral oscillators. Key opportunity lies in potential rebound from oversold RSI levels, while major risks include low liquidity and limited market depth. Investors should monitor breakout above Rp120 resistance for trend reversal confirmation.
VENOM displays limited market activity with a modest market cap of Rp340.86M and only 13% of its maximum 8M token supply in circulation. The asset shows minimal trading volume and network activity, with an average hold time of 24 days indicating cautious investor behavior. No recent protocol updates or significant ecosystem developments have been observed, suggesting stagnant project growth.
Overall outlook remains cautious due to limited liquidity and adoption. Key opportunity lies in potential future protocol development, while major risks include extreme volatility from low market depth and regulatory uncertainty in the crypto space. Investors should monitor for any signs of renewed developer activity or exchange listings.
About Sign
Sign is developing global infrastructure for credential verification and token distribution through two main products. The Sign Protocol is an omni-chain attestation protocol that supports digital public infrastructure for governments and serves as a foundational layer for decentralized applications. TokenTable is a smart contract-based platform that streamlines token distribution processes such as airdrops, vesting, and unlocks, allowing for seamless and transparent on-chain management.
Read more on SIGN →About Venom
Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →
